Home News Insights Trading halts Paper trading Guide Community My account

Market calendarChecking market schedule

Display in USD

Loading news article.

About WAPE
U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption | WAPE

Back All news

NewsPR Newswire

Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption

Nov 5, 2026, 08:02 ET · Published

View source

Article summary

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) (the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class,...

An excerpt from the original article.

Related companies

Lakewood-Amedex Biotherapeutics Inc. Common StockLABTView stock

Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption

Article summary

Related companies

Analyzed by WAPE AI.

Comments —